Novel Immunotherapy for Cancer Takes Cue From Transplant Rej

A novel immunotherapy treatment works by triggering genetically modified T cells to reject cancer, much as they would a transplanted organ, researchers say.

Related Keywords

New York , United States , Oslo , Norway , Iannis Aifantis , Johanna Olweus , Langone Health , Oslo University Hospital Radiumhospitalet , Reuters Health , Department Of Pathology , University Of Oslo , Nature Biology , New York City , Nature Biotechnology , Biologic Therapy , Iologics , Cancer , Alignant Neoplasia , Arcinoma , Alignant Neoplasm , Immunotherapy , Transplantation , Transplant , Chemotherapy , T Cell Receptor , Genetics , Genomics Genomic Medicine , Cellular Rejection , Graft Rejection , Transplant Rejection , Hematology Haematology , Leukemia Leukaemia , T Cell , Slymphocytes ,